Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome. [electronic resource]
Producer: 20180213Description: 55264-55275 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Azacitidine -- therapeutic use
- DNA (Cytosine-5-)-Methyltransferases -- genetics
- DNA Methylation -- drug effects
- DNA Methyltransferase 3A
- DNA-Binding Proteins -- genetics
- Dioxygenases
- Female
- Genes, p53
- Genes, ras
- Humans
- Male
- Middle Aged
- Mutation
- Myelodysplastic Syndromes -- drug therapy
- Prognosis
- Proto-Oncogene Proteins -- genetics
- Splicing Factor U2AF -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.